Natriuretic peptides and long-term mortality in patients with severe aortic stenosis

Journal of Heart Valve Disease

Volumn 21, Issue 3, 2012, Pages 331-336

  Katz, Marcelo ^a,b   Tarasoutchi, Flavio ^a   Pesaro, Antonio Eduardo Pereira ^b   Lopes, Renato D ^c   Spina, Guilherme Sobreira ^a   Vieira, Marcelo Luiz Campos ^a   Grinberg, Max ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD SAMPLING; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; AORTA VALVE; AORTA VALVE STENOSIS; DISEASE MANAGEMENT; ECHOGRAPHY; HOSPITALIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SURVIVAL RATE; SURVIVOR; TREATMENT OUTCOME;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; DISEASE MANAGEMENT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PEPTIDE FRAGMENTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SURVIVORS;

EID: 84866024569     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225
2. Ross J, Jr., Braunwald E. Aortic stenosis. Circulation 1968;38:61-67
3. Carabello BA. Clinical practice. Aortic stenosis. N Engl J Med 2002;346:677-682
4. Carabello BA. Evaluation and management of patients with aortic stenosis. Circulation 2002;105:1746-1750
5. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). Circulation 2008;118:e523-e661
6. Ikeda T, Matsuda K, Itoh H, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 1997;133:307-314
7. Talwar S, Downie PF, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro BNP and cardiotroponin- 1 are elevated in aortic stenosis. Eur J Heart Fail 2001;3:15-19
8. Prasad N, Bridges AB, Lang CC, et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J 1997;133:477-479
9. Qi W, Mathisen P, Kjekshus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001;142:725-732
10. .Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94:740-745
11. Gerber IL, Stewart RA, Leggett ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-1890
12. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-2308
13. Lim P, Monin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: Role of B-type natriuretic peptide. Eur Heart J 2004;25:2048-2053
14. Nessmith MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol 2005;96:1445-1448
15. Neverdal NO, Knudsen CW, Husebye T, et al. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis: One year follow-up. Eur J Heart Fail 2006;8:257-262
16. Pedrazzini GB, Masson S, Latini R, et al. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol 2008;102:749-754
17. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458
18. Currie PJ, Seward JB, Reeder GS, et al. Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: A simultaneous Doppler-catheter correlative study in 100 adult patients. Circulation 1985;71:1162-1169
19. Wyatt HL, Heng MK, Meerbaum S, et al. Cross-sectional echocardiography. II. Analysis of mathematic models for quantifying volume of the formalin-fixed left ventricle. Circulation 1980;61:1119-1125
20. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463
21. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-617
22. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990;15:1012-1017
23. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-2270
24. Dal-Bianco JP, Khandheria BK, Mookadam F, Gentile F, Sengupta PP. Management of asymptomatic severe aortic stenosis. J Am Coll Cardiol 2008;52:1279-1292
25. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: Molecular aspects. Eur J Heart Fail 2004;6:261-268
26. Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 2004;6:295-300
27. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243